BIGG

Início > Guias GRADE > Resultado da busca

Resultados: 3

2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of Polyarteritis Nodosa

Chung, Sharon; Gorelik, Mark; Langford, Carol; Maz, Mehrdad; Abril, Andy; Guyatt, Gordon; Archer, Amy; Conn, Doyt; Full, Kathy; Grayson, Peter; Ibarra, Maria; Mustafa, Reem.
Arthritis care res; 73 (8), 2021
To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for systemic...
Poliarterite Nodosa/diagnóstico por imagem, Poliarterite Nodosa/tratamento farmacológico, Poliarterite Nodosa/prevenção & controle, Glucocorticoides/uso terapêutico, Rituximab/uso terapêutico, Ciclofosfamida/uso terapêutico
Texto completo

2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis

Harigai, Masayoshi; Nagasaka, Kenji; Amano, Koichi; Bando, Masashi; Dobashi, Hiroaki; Kawakami, Tamihiro; Kishibe, Kan; Yohko, Murakawa; Usui, Joichi; Wada, Takashi; Tanaka, Eiichi; Nango, Eishu; Nakayama, Takeo; Tsutsumino, Michi; Yamagata, Kunihiro; Sakae, Homma; Yoshihiro, Arimua.
Mod. rheumatol; 29 (1), 2019
The Japan Research Committee for Intractable Vasculitis has fully revised the clinical practice guidelines (CPG) for the management of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) to improve and standardize the medical treatment of the disease in Japan. The previous CPG was published i...
Vasculite Associada a Anticorpo Anticitoplasma de Neutrófilos/terapia, Azatioprina/administração & dosagem, Azatioprina/uso terapêutico, Ciclofosfamida/uso terapêutico, Quimioterapia de Manutenção, Rituximab/uso terapêutico, Plasmaferese/métodos
Texto completo

Guía de práctica clínica sobre la atención a las personas con esclerosis múltiple

La Agència d’Informació, Avaluació i Qualitat en Salut; Centre d'Esclerosi Múltiple de Catalunya.
Elaborar una guía de practica clínica (GPC) para orientar a los profesionales sanitarios en la toma de decisiones y disminuir la variabilidad en la atención a las personas con Esclerosis múltiple (EM). Proporcionar información útil para los pacientes, familiares y cuidadores que les permita conocer...
Esclerose Múltipla/terapia, Esclerose Múltipla/diagnóstico por imagem, Esclerose Múltipla/tratamento farmacológico, Espectroscopia de Ressonância Magnética/métodos, Interferon beta/uso terapêutico, Acetato de Glatiramer/uso terapêutico, Azatioprina/uso terapêutico, Natalizumab/uso terapêutico, Cloridrato de Fingolimode/uso terapêutico, Mitoxantrona/uso terapêutico, Metotrexato/uso terapêutico, Ciclofosfamida/uso terapêutico, Transplante de Células-Tronco Hematopoéticas, Corticosteroides/uso terapêutico
Texto completo